Evidence map›Paper›PMID 25591951›Full record

ArticleAAPS PharmSciTech2015

Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.

Balamurugan Jeganathan, Vijayalakshmi Prakya

Abstract read
In one paragraph

Article in AAPS PharmSciTech, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. From prediction to performance:International journal of pharmaceutics: X · 2026
    Article
  2. Article
  3. In Vitro Larvicidal Efficacy of a Fipronil-Based Nanoixodicide AgainstTropical medicine and infectious disease · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Preparation of Curcumin-EudragitMolecules (Basel, Switzerland) · 2021
    Article
  8. Pollen grains as a novel microcarrier for oral delivery of proteins.International journal of pharmaceutics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Balamurugan JeganathanDepartment of Pharmacy, Jawaharlal Nehru Technological University Hyderabad, Hyderabad, Andhra Pradesh, India, balamurugan.jeganathan@mylan.in.
Vijayalakshmi Prakya

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to compare a novel controlled release tablet formulation based on interpolyelectrolyte complex (PEC). Interpolymer interactions between the countercharged polymers like Eudragit® EPO (polycation) and hypromellose acetate succinate (polyanion) and Eudragit® EPO and hypromellose phthalate (polyanion) were investigated with a view to their use in per oral controlled release drug delivery systems. The formation of inter-macromolecular ionic bonds between cationic polymer and anionic polymer was investigated using Fourier transform infrared (FT-IR) spectroscopy and differential scanning calorimetry. The FT-IR spectra of the tested polymeric matrices are characterized by visible changes in the observed IR region indicating the interaction between chains of two oppositely charged copolymers. The performance of the in situ formed PEC as a matrix for controlled release of drugs was evaluated, using acetaminophen as a model drug. The dissolution data of these matrices were fitted to different dissolution models. It was found that drug release followed zero-order kinetics and was controlled by the superposition of the diffusion and erosion. These profiles could be controlled by conveniently modifying the proportion of the polymer ratio, polymer type, and polymer concentration the in the tablets.

Indexed as

Drug CarriersElectrolytesAdministration, OralCalorimetry, Differential ScanningHypromellose DerivativesMethylcellulosePharmacokineticsPolymethacrylic AcidsSolubilitySpectroscopy, Fourier Transform InfraredDrug CarriersElectrolytesEudragit E POhydroxypropyl methylcellulose phthalateHypromellose DerivativesMethylcellulosePolymethacrylic Acids

Identifiers

PMID25591951
PMCPMC4508292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.